210 related articles for article (PubMed ID: 35095771)
1. Accelerated Development With Increased Bone Mass and Skeletal Response to Loading Suggest Receptor Activity Modifying Protein-3 as a Bone Anabolic Target.
Pacharne S; Livesey M; Kadmiel M; Wang N; Caron KM; Richards GO; Skerry TM
Front Endocrinol (Lausanne); 2021; 12():807882. PubMed ID: 35095771
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cardiovascular development and homeostasis by the adrenomedullin-RAMP system.
Shindo T; Tanaka M; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Yamauchi A; Sakurai T
Peptides; 2019 Jan; 111():55-61. PubMed ID: 29689347
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin-RAMP2 and -RAMP3 Systems Regulate Cardiac Homeostasis during Cardiovascular Stress.
Cui N; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Tanaka M; Tanaka M; Wei Y; Kakihara S; Zhao Y; Aruga K; Kawagishi H; Nakada T; Yamada M; Shindo T
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33545715
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
5. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
6. Receptor activity-modifying proteins of adrenomedullin (RAMP2/3): Roles in the pathogenesis of ARDS.
Kasahara T; Tanaka M; Zhao Y; Kamiyoshi A; Sakurai T; Ichikawa-Shindo Y; Kawate H; Matsuda Y; Zhang Y; Guo Q; Li P; Hoshiyama K; Li J; Onishi N; Hayashi M; Sanjo H; Ishida K; Tanaka S; Kawamata M; Shindo T
Peptides; 2024 Jan; 171():171118. PubMed ID: 38012983
[TBL] [Abstract][Full Text] [Related]
7. Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age.
Dackor R; Fritz-Six K; Smithies O; Caron K
J Biol Chem; 2007 Jun; 282(25):18094-18099. PubMed ID: 17470425
[TBL] [Abstract][Full Text] [Related]
8. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking.
Bomberger JM; Parameswaran N; Hall CS; Aiyar N; Spielman WS
J Biol Chem; 2005 Mar; 280(10):9297-307. PubMed ID: 15613468
[TBL] [Abstract][Full Text] [Related]
9. Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1.
Bomberger JM; Spielman WS; Hall CS; Weinman EJ; Parameswaran N
J Biol Chem; 2005 Jun; 280(25):23926-35. PubMed ID: 15805108
[TBL] [Abstract][Full Text] [Related]
10. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
11. Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system.
Yamauchi A; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Igarashi K; Toriyama Y; Tanaka M; Liu T; Xian X; Imai A; Zhai L; Owa S; Arai T; Shindo T
J Mol Cell Cardiol; 2014 Dec; 77():73-85. PubMed ID: 25264174
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor.
Armour SL; Foord S; Kenakin T; Chen WJ
J Pharmacol Toxicol Methods; 1999 Dec; 42(4):217-24. PubMed ID: 11033437
[TBL] [Abstract][Full Text] [Related]
13. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
14. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
15. Shared and separate functions of the RAMP-based adrenomedullin receptors.
Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.
Kuwasako K; Kitamura K; Nagata S; Nozaki N; Kato J
Biochem Biophys Res Commun; 2012 Apr; 420(3):582-7. PubMed ID: 22445753
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin and its receptor complexes in remnant kidneys of rats with renal mass ablation: decreased expression of calcitonin receptor-like receptor and receptor-activity modifying protein-3.
Totsune K; Takahashi K; Mackenzie HS; Arihara Z; Satoh F; Sone M; Murakami O; Ito S; Brenner BM; Mouri T
Peptides; 2001 Nov; 22(11):1933-7. PubMed ID: 11754984
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor.
Harikumar KG; Simms J; Christopoulos G; Sexton PM; Miller LJ
Biochemistry; 2009 Dec; 48(49):11773-85. PubMed ID: 19886671
[TBL] [Abstract][Full Text] [Related]
19. Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs).
Fischer JA; Muff R; Born W
Biochem Soc Trans; 2002 Aug; 30(4):455-60. PubMed ID: 12196114
[TBL] [Abstract][Full Text] [Related]
20. Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.
Watkins HA; Chakravarthy M; Abhayawardana RS; Gingell JJ; Garelja M; Pardamwar M; McElhinney JM; Lathbridge A; Constantine A; Harris PW; Yuen TY; Brimble MA; Barwell J; Poyner DR; Woolley MJ; Conner AC; Pioszak AA; Reynolds CA; Hay DL
J Biol Chem; 2016 May; 291(22):11657-75. PubMed ID: 27013657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
